Bioheart, Inc. , a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it has entered into an agreement with StemMD.
http://www.biospace.com/news_story.aspx?StoryID=317499&full=1
http://www.biospace.com/news_story.aspx?StoryID=317499&full=1
No comments:
Post a Comment